Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14

Deprecated: Function jetpack_form_register_pattern is deprecated since version jetpack-13.4! Use Automattic\Jetpack\Forms\ContactForm\Util::register_pattern instead. in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 6078
The Lokpal and Lokayuktas Bill, 2013 - The Pharma Times | Pharma & Health Care News Portal
Categories: Policy

The Lokpal and Lokayuktas Bill, 2013

New Delhi December 19, 2013: The Rajya Sabha passed the Lokpal and Lokayuktas Bill, 2011 on December 17, 2013 and the Bill has been passed by the Lok Sabha today. 

 Some of the important features in the Bill are as below:-

·         Lokpal at the Centre and Lokayukta at the level of the States.

·         The Lokpal will consist of a Chairperson and a maximum of eight Members, of which fifty percent shall be judicial members.

·         Fifty per cent of members of Lokpal shall be from amongst SC/ST/OBCs, Minorities and Women.

·         The selection of Chairperson and Members of Lokpal shall be through a Selection Committee consisting of:-

§  Prime Minister;

§  Speaker of Lok Sabha;

§  Leader of Opposition  in the Lok Sabha;

§  Chief Justice of India or a sitting Supreme Court judge nominated  by CJI;

§  Eminent jurist to be nominated by the President of India on the basis of recommendations of the first four members of the Selection Committee.  

·         Prime Minister has been brought under the purview of the Lokpal.

·         Lokpal’s jurisdiction will cover all categories of public servants.

·         All entities receiving donations from foreign source in the context of the Foreign Contribution Regulation Act (FCRA) in excess of Rs. 10 lakhs per year are brought under the jurisdiction of Lokpal.

·         Provides adequate protection for honest and upright Public Servants.

·         Lokpal will have power of superintendence and direction over any investigation agency including CBI for cases referred to them by Lokpal.

·         A high powered Committee chaired by the Prime Minister will recommend selection of the Director,CBI.

·         Directorate of Prosecution headed by a Director of Prosecution under the overall control of Director;

·         The appointment of the Director of Prosecution, CBI on the recommendation of the Central Vigilance Commission;

·         Transfer of officers of CBI investigating cases referred by Lokpal with the approval of Lokpal;

·         The Bill also incorporates provisions for attachment and confiscation of property acquired by corrupt means, even while prosecution is pending.

·         The Bill lays down clear time lines for Preliminary enquiry & investigation and trial and

towards this end, the Bill provides for setting up of Special Courts.

·         A mandate for setting up of the institution of Lokayukta through enactment of a law by the State Legislature within a period of 365 days from the date of commencement of the Act.

The Pharma Times News Bureau

Recent Posts

Fortis Hospital, Bannerghatta Road Launches dedicated Parkinson’s Disease and Deep Brain Stimulation Clinic

-  This specialized division empowers patients with neurological disorders to reclaim their mobility through a…

7 days ago

Milestone set in Indian Medical History – SSI Mantra Surgical Robotic System Performs the First-Ever Successful Surgery on One-Year-Old Infant

SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…

1 week ago

Manipal Hospital Ghaziabad organises Fire Safety Training to Enhance Emergency Response

Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…

2 weeks ago

Professor Dr Robert Zeiser receives DKMS Mechtild Harf Science Award 2024

DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…

3 weeks ago

Dr. Reddy’s launches drug-free migraine management device Nerivio® in Europe following successful launch in India

Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…

3 weeks ago

Ankura Hospital Doctors perform a successful Complex Lung Surgery on a 4-month-old Infant

 Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…

4 weeks ago